Take-Two Interactive Software (NASDAQ:TTWO – Get Free Report)‘s stock had its “outperform” rating restated by investment analysts at Wedbush in a note issued to investors on Thursday, Marketbeat Ratings reports. They presently have a $190.00 price target on the stock. Wedbush’s price target would suggest a potential upside of 6.80% from the company’s previous close. […]

Royal Bank of Canada reaffirmed their outperform rating on shares of Inspire Medical Systems (NYSE:INSP – Free Report) in a research report report published on Tuesday morning,Benzinga reports. Royal Bank of Canada currently has a $260.00 price target on the stock. Other analysts have also issued reports about the company. Leerink Partners increased their target […]

Wedbush reissued their outperform rating on shares of Nuvation Bio (NYSE:NUVB – Free Report) in a research note released on Thursday,RTT News reports. The firm currently has a $5.00 price objective on the stock. Several other analysts have also weighed in on the company. HC Wainwright reduced their price objective on Nuvation Bio from $8.00 […]

William Blair reiterated their outperform rating on shares of Simulations Plus (NASDAQ:SLP – Free Report) in a report released on Wednesday,Benzinga reports. William Blair also issued estimates for Simulations Plus’ Q1 2025 earnings at $0.16 EPS, Q2 2025 earnings at $0.27 EPS, Q3 2025 earnings at $0.32 EPS, Q4 2025 earnings at $0.37 EPS, FY2025 […]

Take-Two Interactive Software (NASDAQ:TTWO – Get Free Report) had its price target increased by research analysts at UBS Group from $156.00 to $175.00 in a report issued on Thursday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s price target points to a potential downside of 1.63% from the company’s previous […]